Lim Lim M M Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter Neuro Oncol Neuro Oncol 2022 2022 24 24 11 11 1935 1935 1949 1949 10.1093/neuonc/noac116 10.1093/neuonc/noac116 supplied-pmid 35511454? Here, MGMT is linked to glioblastoma.